-
1Academic Journal
Authors: A. P. Lykov, M. A. Surovtseva, O. V. Poveshchenko, A. M. Chernyavsky, A. V. Fomichev, N. A. Bondarenko, I. I. Kim, А. П. Лыков, М. А. Суровцева, О. В. Повещенко, А. М. Чернявский, А. В. Фомичев, Н. А. Бондаренко, И. И. Ким
Source: Medical Immunology (Russia); Том 22, № 1 (2020); 135-142 ; Медицинская иммунология; Том 22, № 1 (2020); 135-142 ; 2313-741X ; 1563-0625
Subject Terms: пролиферация, bone marrow, mononuclear cells, phenotype, cell cycle, apoptosis, proliferation, костномозговые мононуклеары, фенотип, клеточный цикл, апоптоз
File Description: application/pdf
Relation: https://www.mimmun.ru/mimmun/article/view/1807/1230; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1807/5189; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1807/5190; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1807/5191; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1807/5192; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1807/5193; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1807/5194; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1807/5195; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1807/5196; Захаров Ю.М. Цитопротекторные функции эритропоэтина // Клиническая нефрология. 2009. № 1. С. 16-21. [Zakharov Yu.M. Citoprotective effects of erythropoietin. Klinicheskaya nefrologiya = Clinical Nephrology, 2009, no. 1, pp. 16-21. (In Russ.)]; Лыков А.П., Бондаренко Н.А., Сахно Л.В., Шевела Е.Я., Повещенко О.В., Ким И.И., Никонорова Ю.В., Коненков В.И. Влияние секреторных факторов эндотелиальных клеток на пролиферативную и миграционную способность мультипотентных мезенхимальных стромальных клеток человека // Фундаментальные исследования, 2014. № 4, ч. 2. С. 36-42. [Lykov A.P., Bondarenko N.A., Sakhno L.V., Shevela E.Ya., Poveschenko O.V., Kim I.I., Nikonorova Yu.V., Konenkov V.I. The impact of secretory factors endothelial cells on the functional activity of human multipotent mesenchymal stromal cells. Fundamentalnye issledovaniya = Fundamental Research, 2014, no. 4, Pt 2, pp. 36-42. (In Russ.)]; Лыков А.П., Никонорова Ю.В., Бондаренко Н.А., Повещенко О.В., Ким И.И., Повещенко А.Ф., Коненков В.И. Изучение пролиферации, миграции и продукции оксида азота костномозговыми мультипотентными мезенхимными стромальными клетками крыс Вистар при гипоксии и гипергликемии // Бюллетень экспериментальной биологии и медицины, 2015. Т. 159, № 4. С. 432-434. [Lykov A.P., Nikonorova Yu.V., Bondarenko N.A., Poveshchenko O.V., Kim I.I., Poveshchenko A.F., Konenkov V.I. Proliferation, migration, and production of nitric oxide by bone marrow multipotent mesenchymal stromal cells from Wistar rats in hypoxia and hyperglycemia. Byulleten eksperimentalnoy biologii i meditsiny = Bulletin of Experimental Biology and Medicine, 2015, Vol. 159, no. 4, pp. 432-434. (In Russ.)]; Осиков М.В., Ахматов В.Ю., Телешева Л.Ф., Федосов А.А., Агеев Ю.И., Суровяткина Л.Г. Плейотропные эффекты эритропоэтина при хронической почечной недостаточности // Фундаментальные исследования, 2013. № 7, ч. 1. С. 218-224. [Osikov M.V., Akhmatov V.Yu., Telesheva L.F., Fedosov A.A., Ageev Yu.I., Surovyatkina L.G. Pleiotropic effects of erythropoietin in chronic renal failure. Fundamentalnye issledovaniya = Fundamental Research, 2013, no. 7, Pt 1, pp. 218-224. (In Russ.)]; Bennis Y., Sarlon-Bartoli G., Guillet B., Lucas L., Pellegrini L., Velly L., Blot-Chabaud M., Dignat-Georges F., Sabatier F., Pisano P. Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD131 receptor subunit and enhances their angiogenic potential. J. Thromb. Haemost. 2012, Vol. 10, no. 9, pp. 1914-1928.; Hristov M., Zernecke A., Bidzhekov K., Liehn E.A., Shagdarsuren E., Ludwig A., Weber C. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ. Res., 2007, Vol. 100, no. 4, pp. 590-597.; Hu R., Cheng Y., Jing H., Wu H. Erythropoietin promotes the protective properties of transplanted endothelial progenitor cells against acute lung injury via PI3K/Akt pathway. Shock, 2014, Vol. 42, no. 4, pp. 327-336.; Jang W.Y., Kim H.J., Li H., Jo K.D., Lee M.K., Yang H.O. The neuroprotective effect of erythropoietin on rotenone-induced neurotoxicity in SH-SY5Y cells through the induction of autophagy. Mol. Neurobiol., 2016, Vol. 53, pp. 3812-3821.; Kahraman S., Yilmaz R., Kirkpantur A., Genctoy G., Arici M., Altun B., Erdem Y., Yasavul U., Turgan C. Impact of rHuEPO therapy initiation on soluble adhesion molecule levels in haemodialysis patients. Nephrology (Carlton), 2005, Vol. 10, no. 3, pp. 264-269.; Kamianowska M., Szczepanski M., Skrzydlewska E. Effects of erythropoietin on ICAM-1 and PECAM-1 expressions on human umbilical vein endothelial cells subjected to oxidative stress. Cell Biochem. Funct., 2011, Vol. 29, no. 6, pp. 437-441.; Kandala J., Upadhyay G.A., Pokushalov E., Wu S., Drachman D.E., Singh J.P. Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy. Am. J. Cardiol., 2013, Vol. 112, no. 2, pp. 217-225.; Kang J., Yun J.Y., Hur J., Kang J.A., Choi J.I., Ko S.B., Lee J., Kim J.Y., Hwang I.C., Park Y.B., Kim H.S. Erythropoietin priming improves the vasculogenic potential of G-CSF mobilized human peripheral blood mononuclear cells. Cardiovasc. Res., 2014, Vol. 104, no. 1, pp. 171-182.; Lykov A.P., Poveshchenko O.V., Cherniavsky A.M., Fomichev A.V., Surovtseva M.A., Bondarenko N.A., Kim I.I., Kareva Y.E., Tarkova A.R. Phenotype of bone marrow mononuclear cells before and after short-time precondition with Erythropoietin from patients with ischemic heart failure. Russian Open Medical Journal, 2018, Vol. 7, no. 2, pp. 202-208.; Liu N.M., Tian J., Wang W.W., Han G.F., Cheng J., Huang J., Zhang J.Y. Effects of erythropoietin on mesenchymal stem cells function of differentiation and secretion cultured under acute kidney injury microenvironment. Zhonghua Yi Xue Za Zhi, 2012, Vol. 92, no. 6, pp. 417-421.; Madigan M., Atoui R. Therapeutic use of stem cells for myocardial infarction. Bioengineering (Basel), 2018, Vol. 5, no. 2, E28. doi:10.3390/bioengineering5020028.; Seurder D., Radrizzani M., Turchetto L., Lo Cicero V., Soncin S., Muzzarelli S., Auricchio A., Moccetti T. Combined delivery of bone marrow-derived mononuclear cells in chronic ischemic heart disease: rationale and study design. Clin. Cardiol., 2013, Vol. 36, no. 8, pp. 435-441.; Mohler E.R. 3rd, Lifeng Zhang, Medenilla E., Rogers W., French B., Bantly A., Moore J.S., Yonghong Huan, Murashima M., Berns J.S. Effect of darbepoetin alfa on endothelial progenitor cells and vascular reactivity in chronic kidney disease. Vasc. Med., 2011, Vol. 16, no. 3, pp. 183-189.; Tse H.F., Siu C.W., Zhu S.G., Songyan L., Zhang Q.Y., Lai W.H., Kwong Y.L., Nicholls J., Lau C.P. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur. J. Heart Failure, 2007, Vol. 9, pp. 747-753.; Wang Q.R., Wang B.H., Zhu W.B., Huang Y.H., Li Y., Yan Q. An in vitro study of differentiation of hematopoietic cells to endothelial cells. Bone Marrow Res., 2011, Vol. 2011, 846096. doi:10.1155/2011/846096.; https://www.mimmun.ru/mimmun/article/view/1807